Division of Urologic Oncology, University of Texas Southwestern Medical Center, Dallas, Texas 45229, USA.
J Urol. 2012 Oct;188(4 Suppl):1506-10. doi: 10.1016/j.juro.2012.02.025. Epub 2012 Aug 19.
Nephron sparing surgery is accepted as standard of care for children with bilateral Wilms tumor or Wilms tumor in a solitary kidney and some study protocols allow nephron sparing surgery in select cases of unilateral Wilms tumor. With the increasing use of nephron sparing surgery in Wilms tumor, we reviewed pathological features from Wilms tumor radical nephrectomy specimens to determine the potential efficacy of a nephron sparing approach.
Medical records of children undergoing pre-chemotherapy radical nephrectomy for unilateral Wilms tumor at our institution were reviewed. Ideal candidates for nephron sparing surgery were defined as those having a unifocal mass outside the renal hilum, sparing a third or more of the kidney, favorable histology, no signs of renal sinus or segmental vascular invasion, no metastatic lymph nodes or gross regional disease, and a distinct interface on pathological review between tumor and remaining parenchyma.
A total of 78 children at a median age of 3.2 years (range 0.3 to 16.2) underwent pre-chemotherapy radical nephrectomy for unilateral Wilms tumor. Median tumor diameter was 11 cm (range 2.5 to 22). Of these children 36 (46.2%) had tumors sparing a third or more of the kidney and 70 (89.7%) had unifocal tumors. There were 73 specimens (94.6%) that showed favorable histology, and 56 (71.8%) of the specimens had a distinct border between tumor and remaining parenchyma. In total, 19 (24.4%) of the patients reviewed met all of our strict pathological criteria as ideal partial nephrectomy candidates.
In a post hoc analysis using strict pathological criteria and accepted surgical oncologic principles, as many as 1 in 4 children undergoing pre-chemotherapy surgery for nonmetastatic, unilateral Wilms tumor have post-resection pathological tumor characteristics favorable for nephron sparing surgery.
保肾手术被认为是双侧肾母细胞瘤或孤立肾肾母细胞瘤患儿的标准治疗方法,一些研究方案允许在单侧肾母细胞瘤的某些情况下进行保肾手术。随着保肾手术在肾母细胞瘤中的应用越来越多,我们回顾了肾母细胞瘤根治性肾切除术后标本的病理特征,以确定保肾手术的潜在疗效。
回顾了本机构接受化疗前单侧肾母细胞瘤根治性肾切除术的儿童的病历。保肾手术的理想候选者定义为:肿瘤位于肾门以外的单一部位,保留 1/3 或以上的肾脏,组织学良好,无肾窦或节段血管侵犯,无转移淋巴结或局部广泛疾病,且病理检查肿瘤与剩余实质之间有明确的界面。
共有 78 名中位年龄为 3.2 岁(范围 0.3 至 16.2 岁)的儿童因单侧肾母细胞瘤接受了化疗前根治性肾切除术。肿瘤直径中位数为 11 厘米(范围 2.5 至 22)。其中 36 名(46.2%)肿瘤保留 1/3 或以上的肾脏,70 名(89.7%)肿瘤为单一部位。73 份标本(94.6%)显示组织学良好,56 份标本(71.8%)肿瘤与剩余实质之间有明确的边界。在总共 19 名(24.4%)接受化疗前手术的患者中,有 19 名符合我们严格的病理标准,被认为是理想的部分肾切除术候选者。
在使用严格的病理标准和公认的外科肿瘤学原则进行的回顾性分析中,多达 1/4 的接受化疗前手术的非转移性单侧肾母细胞瘤患儿,术后病理肿瘤特征有利于保肾手术。